Significant Insider Selling in Shares of Selecta Biosciences (SELB) Continues

Thursday, September 28, 2017 10:15 PM ET

Significant Insider Selling in Shares of Selecta Biosciences (SELB) Continues

A SEC filing today indicated a significant insider sale of Selecta Biosciences shares as — Amir Nashat, Director — disposed of 70,226 shares in the company having a market value of approximately $1,328,079. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 226,398 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 296,624 shares and have averaged 148,312 shares per transaction over this time period.

Selecta Biosciences insider trading represents a higher number of buy/sell transactions than for the 266 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 312 buy/sell trades during this period for an average of 1.2 transactions per company. The number of shares per buy/sell trade for Selecta Biosciences insiders was also higher. Within the peer group there were 8,819,983 shares purchased and 19,144,668 shares sold with company insiders having sold 33,092 shares on average.

The data used in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.